Difference between revisions of "International Mito Patients (IMP)"
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
| Line 5: | Line 5: | ||
|info=[http://www.mitopatients.org/ MitoPatients] | |info=[http://www.mitopatients.org/ MitoPatients] | ||
}} | }} | ||
== Chair of IMP == | |||
:::: Elja van der Veer | |||
:::: Main responsibility: general management, project harmful drugs for mito’s | |||
:::: The Netherlands | |||
:::: Email: [[email protected] [email protected]] | |||
{{MitoPedia topics | {{MitoPedia topics | ||
|mitopedia topic=MitoGlobal Organizations | |mitopedia topic=MitoGlobal Organizations | ||
}} | }} | ||
Revision as of 10:59, 24 February 2017
<nowiki>
- high-resolution terminology - matching measurements at high-resolution
International Mito Patients (IMP)
Description
The International Mito Patients is a network of national patient organizations involved in mitochondrial disease. Mitochondrial disease is a rare disease with a limited number of patients per country. The national patient organizations which are a member of IMP each are active and powerful in their own countries. By joining forces IMP can represent a large group of patients and as such be their voice on an international level.
Abbreviation: IMP
Reference: MitoPatients
Chair of IMP
- Elja van der Veer
- Main responsibility: general management, project harmful drugs for mito’s
- The Netherlands
- Email: [[email protected] [email protected]]
MitoPedia topics: MitoGlobal Organizations
